Oncoceutics Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Employees
-
20
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$81.3M
Oncoceutics General Information
Description
Operator of a clinical-stage drug development company intended to offer class compounds that selectively target G protein-coupled receptors for oncology. The company specializes in the research and development of a lead compound that is an orally active DRD2 small molecule antagonist that is well-tolerated and effective against advanced cancers, enabling the healthcare industry to get access to compounds that control critical signaling pathways in cancer treatments. .
Contact Information
Website
www.oncoceutics.comCorporate Office
- 3675 Market Street
- Suite 200
- Philadelphia, PA 19104
- United States
Corporate Office
- 3675 Market Street
- Suite 200
- Philadelphia, PA 19104
- United States
Oncoceutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 07-Jan-2021 | $81.3M | Completed | Generating Revenue | ||
| 6. Grant | 08-Jun-2020 | Completed | Generating Revenue | |||
| 5. Debt - PPP | 03-May-2020 | Completed | Generating Revenue | |||
| 4. Grant | 27-Jan-2020 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 14-Feb-2018 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 11-Dec-2014 | $2.5M | Completed | Clinical Trials - Phase 1 | ||
| 1. Seed Round | 23-Sep-2014 | $2.5M | $2.5M | Completed | Clinical Trials - Phase 1 |
Oncoceutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 1,137,772 | $0.001000 | $4.28 | $4.28 | 1x | $4.28 | 8.19% | |
| Seed | 2,795,161 | $0.001000 | $0.94 | $0.94 | 1x | $0.94 | 20.12% |
Oncoceutics Comparisons
Industry
Financing
Details
Oncoceutics Competitors (2)
One of Oncoceutics’s 2 competitors is Agenus, a Formerly VC-backed company based in Lexington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Agenus | Formerly VC-backed | Lexington, MA | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA |
Oncoceutics Patents
Oncoceutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2023139152-A | Imipridone for glioma | Active | 03-Nov-2017 | ||
| JP-2026094283-A | Imipridone for gliomas | Pending | 03-Nov-2017 | ||
| AU-2018360752-A1 | Imipridones for gliomas | Inactive | 03-Nov-2017 | ||
| AU-2024219839-A1 | Imipridones for gliomas | Active | 03-Nov-2017 | ||
| AU-2024219839-B2 | Imipridones for gliomas | Active | 03-Nov-2017 | A61K31/519 |
Oncoceutics Signals
Oncoceutics Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Brown University Endowment | Limited Partner | |||
| Calvert Research | Venture Capital | Minority | ||
| Frontida Biopharm | Corporation | Minority | ||
| National Brain Tumor Society | Not-For-Profit Venture Capital | |||
| Science Center | Accelerator/Incubator |
Oncoceutics FAQs
-
When was Oncoceutics founded?
Oncoceutics was founded in 2009.
-
Where is Oncoceutics headquartered?
Oncoceutics is headquartered in Philadelphia, PA.
-
What is the size of Oncoceutics?
Oncoceutics has 20 total employees.
-
What industry is Oncoceutics in?
Oncoceutics’s primary industry is Drug Discovery.
-
Is Oncoceutics a private or public company?
Oncoceutics is a Private company.
-
What is the current valuation of Oncoceutics?
The current valuation of Oncoceutics is .
-
What is Oncoceutics’s current revenue?
The current revenue for Oncoceutics is .
-
How much funding has Oncoceutics raised over time?
Oncoceutics has raised $20.5M.
-
Who are Oncoceutics’s investors?
Brown University Endowment, Calvert Research, Frontida Biopharm, National Brain Tumor Society, and Science Center are 5 of 7 investors who have invested in Oncoceutics.
-
Who are Oncoceutics’s competitors?
Agenus and Inovio Pharmaceuticals are competitors of Oncoceutics.
-
When was Oncoceutics acquired?
Oncoceutics was acquired on 07-Jan-2021.
-
Who acquired Oncoceutics?
Oncoceutics was acquired by Chimerix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process